Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial

The POP Trial Investigators

doi:10.1186/s13063-018-3134-1

Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial

The POP Trial Investigators

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Trials
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s13063-018-3134-1
Publication status	Published - 8 Jan 2019

Access to Document

10.1186/s13063-018-3134-1

s13063-018-3134-1Final published version, 1.08 MBLicence: Creative Commons: Attribution (CC-BY)

https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-018-3134-1

An open label exploratory safety and tolerability study with PP100-01 in Patients Treated with the 12 hour regimen of NAC for paracetamol/acetaminophen overdose
Norrie, J. (Principal Investigator)
Other
1/01/17 → 30/06/18
Project: Research

Cite this

The POP Trial Investigators (2019). Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial. Trials, 20(1). https://doi.org/10.1186/s13063-018-3134-1

@article{6c88710262314d2fb0754e95883b987e,

title = "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial",

author = "{The POP Trial Investigators} and James Dear",

year = "2019",

month = jan,

day = "8",

doi = "10.1186/s13063-018-3134-1",

language = "English",

volume = "20",

journal = "Trials",

issn = "1745-6215",

publisher = "BMC",

number = "1",

}

The POP Trial Investigators 2019, 'Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial', Trials, vol. 20, no. 1. https://doi.org/10.1186/s13063-018-3134-1

Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial. / The POP Trial Investigators.
In: Trials, Vol. 20, No. 1, 08.01.2019.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial

AU - The POP Trial Investigators

AU - Dear, James

PY - 2019/1/8

Y1 - 2019/1/8

U2 - 10.1186/s13063-018-3134-1

DO - 10.1186/s13063-018-3134-1

M3 - Article

SN - 1745-6215

VL - 20

JO - Trials

JF - Trials

IS - 1

ER -

Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial

Access to Document

Projects

An open label exploratory safety and tolerability study with PP100-01 in Patients Treated with the 12 hour regimen of NAC for paracetamol/acetaminophen overdose

Cite this